/

/

Automated Processor for Clinical-Scale CAR-T Cell Manufacturing

/

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Journal JoVE
Médecine

Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.

Journal JoVE Médecine

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Automated Processor for Clinical-Scale CAR-T Cell Manufacturing

DOI:

10.3791/65488-v

•

01:25 min

•

August 18, 2023

•

Rene Machietto, Nicholas Giacobbe, Jessica Perazzelli, Ted J. Hofmann, Allison Barz Leahy³, Stephan A. Grupp^2,3, Yongping Wang^3,4, Stephan Kadauke^3,4

¹Cell and Gene Therapy Laboratory, Department of Pathology and Laboratory Medicine,Children’s Hospital of Philadelphia, ²Division of Oncology, Department of Pediatrics,Children’s Hospital of Philadelphia, ³Perelman School of Medicine at the University of Pennsylvania, ⁴Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine,Children’s Hospital of Philadelphia

Tags

CAR-T Cell Manufacturing Automated Cell Processing Closed System Semi-automated Customizable Protocol Cost-effective Cell And Gene Therapy Immunotherapy CliniMACS Prodigy T Cell Transduction CGMP Compliance IND Application

Embed

AJOUTER À LA PLAYLIST

Usage Statistics

Vidéos Connexes

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Manufacturing Chimeric Antigen Receptor T-Cells Using an Automated Cell Processor

Read Article